Company

AstraZeneca (LSE:AZN)

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

About AZN

Related Articles

Investing Articles

Is AstraZeneca plc Still A Buy After The 2013 FTSE Bull Run?

AstraZeneca plc (LON:AZN) has kept pace with the FTSE this year, but remains an appealing recovery story.

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: Drax Group Plc, Smith & Nephew plc and AstraZeneca plc

Drax Group Plc (LON: DRX), Smith & Nephew plc (LON: SN) and AstraZeneca plc (LON: AZN) are soaring.

Read more »

Investing Articles

AstraZeneca plc Could Help You Retire Early

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why...

Read more »

Investing Articles

Can AstraZeneca plc’s Share Price Return To 3,625p?

Will AstraZeneca plc (LON: AZN) be able to return to its previous highs?

Read more »

Investing Articles

The Warren Buffett Bear Case For AstraZeneca plc

A Buffett fan considers the investment case for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

AstraZeneca plc Could Be Worth 3915p

Shareholders in AstraZeneca plc (LON: AZN) could enjoy gains of 18.5% plus a generous dividend. Here’s why…

Read more »

Investing Articles

Why AstraZeneca plc Will Be One Of 2013’s Winners

It's a close run for AstraZeneca plc (LON: AZN) as we approach the end of the year.

Read more »

Investing Articles

A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc

What are the key factors affecting the investment proposition at pharmaceutical giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN)?

Read more »

Investing Articles

Angels vs Devils: Should You Invest In AstraZeneca plc?

Royston Wild considers the pros and cons of investing in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

This Model Suggests AstraZeneca plc Could Deliver A 6.3% Annual Return

Roland Head explains why AstraZeneca plc (LON:AZN) could deliver a 6.3% annual return over the next few years.

Read more »